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Inflammatory (Ly6Chi CCR2+) monocytes provide
defenseagainst infectionsbut alsocontribute toauto-
immune diseases and atherosclerosis. Monocytes
originate from bone marrow and their entry into the
bloodstream requires stimulation ofCCR2chemokine
receptor bymonocyte chemotactic protein-1 (MCP1).
How monocyte emigration from bone marrow is trig-
gered by remote infections remains unclear. We
demonstrated that low concentrations of Toll-like
receptor (TLR) ligands in the bloodstream drive
CCR2-dependent emigration of monocytes from
bonemarrow. Bonemarrowmesenchymal stem cells
(MSCs) and their progeny, including CXC chemokine
ligand (CXCL)12-abundant reticular (CAR) cells,
rapidly expressed MCP1 in response to circulating
TLR ligands or bacterial infection and induced mono-
cyte trafficking into the bloodstream. Targeted dele-
tion of MCP1 fromMSCs impaired monocyte emigra-
tion from bone marrow. Our findings suggest that
bone marrow MSCs and CAR cells respond to circu-
lating microbial molecules and regulate bloodstream
monocyte frequencies by secreting MCP1 in prox-
imity to bone marrow vascular sinuses.
INTRODUCTION
Recruitment of inflammatory cells to sites of infection is essential
for innate immune defense against microbial pathogens (Medz-
hitov, 2007; Serbina et al., 2008). Induction of host chemokine
secretion by microbes and establishment of gradients to guide
inflammatory cells to sites of infection serves as a widely
accepted paradigm for antimicrobial defense (Handel et al.,590 Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc.2005; Rot and von Andrian, 2004). Deficiencies in chemokine
receptors or specific chemokines are associated with defective
immune responses to infection and delayed clearance of viral,
bacterial, and protozoal pathogens (Dunay et al., 2008; Glass
et al., 2005; Glass et al., 2006; Kurihara et al., 1997).
Althoughstudiesof chemokine-mediated recruitmentof inflam-
matory cells have principally focused on trafficking across the
endothelium from the bloodstream into infected tissues
(Randolph et al., 1998), recent studies demonstrate that chemo-
kines induced during early stages of microbial infection promote
emigration of inflammatory cells from the bone marrow into the
bloodstream.Neutrophils and inflammatorymonocytes represent
two bone marrow-derived cell populations that are essential for
antimicrobial defense. Neutrophil emigration from bone marrow
involves a finely modulated balance of retention and release
mediated by the chemokine receptors CXCR2 and CXCR4
(Eash et al., 2010; Martin et al., 2003). In contrast to neutrophil
recruitment, inflammatory monocyte recruitment during infection
requires stimulation of the CCR2 chemokine receptor in order to
trigger release of cells from thebonemarrow into the bloodstream
(Serbina and Pamer, 2006; Tsou et al., 2007). However, little is
known about the regulation of monocyte emigration from bone
marrow beyond a requirement for CCR2 signaling (Crane et al.,
2009; Serbina and Pamer, 2006; Tsou et al., 2007).
It is unclear how infections in peripheral tissues or in central
organs promote monocyte emigration from bone marrow. One
possibility is that low-grade infection of the bonemarrow directly
stimulates monocyte emigration, a scenario for which there is
little evidence and which seems counterintuitive (i.e., dispatch-
ing inflammatory cells away from a site of infection). Alternatively,
cells at a site of focal infection might produce chemokines that
enter the circulation and trigger responses in the bone marrow.
This model, given the dilution of chemokines in plasma and
their potentially rapid clearance by decoy chemokine-receptors
(Jamieson et al., 2005; Rot, 2005), would require massive
chemokine secretion at the site of infection in order to trigger
responses in remote sites in the bone marrow. Although
Figure 1. Low Amounts of LPS Drive Monocyte Emigration from the Bone Marrow
(A) Increased circulating monocytes were identified as CD11b+Ly6Chi by flow cytometry. Flow cytometry plots are gated on CD45+ nucleated cells.
(B) Wild-type (WT) and TLR4-deficient mice were injected intraperitoneally (i.p.) with 2 ng LPS. Blood was obtained at the indicated time points after inoculation
and analyzed by flow cytometry for determining CD11b+Ly6Chi monocyte percentages in CD45+ nucleated cells in the circulation.
(C) WT mice were inoculated with PBS or 20 pg to 2 mg LPS and blood monocyte frequencies were determined 4 hr after LPS injection.
(D)WTmice were inoculated with 2 ng LPS. Four hours later, blood, bonemarrow, and spleen monocyte frequencies were determined. Data are representative of
three to seven mice per group from at least three independent experiments, represented as mean ± SEM.
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during later stages of infection, in most scenarios inflammatory
cells have already been recruited to primary sites of infection
at earlier time points (Crane et al., 2009; Jia et al., 2008).
A third possibility is that cells in the bone marrow detect low
levels of circulating microbial molecules during infection and, in
response, express chemokines that promote inflammatory cell
emigration into the bloodstream. Evidence for this model is
limited, and most studies of chemokine expression in bone
marrow have focused on the retention and release of neutrophils
and hematopoietic stem cells (Eash et al., 2010; Martin et al.,
2003; Sugiyama et al., 2006).
We have generated CCR2 and monocyte chemotactic
protein-1 (MCP1) reporter mice to investigate in vivo emigration
of inflammatorymonocytes from the bonemarrow in response to
low levels of circulating Toll-like receptor (TLR) ligands and
after infection with the intracellular bacterial pathogen Listeria
monocytogenes. Intravenous administration of nanomolar
concentrations of lipopolysaccharide (LPS) induced emigration
of monocytes from the bone marrow into the bloodstream.
MCP1-reporter mice revealed that LPS administration or infec-
tion with L. monocytogenes induced rapid expression of MCP1
by cells that were tightly associated with endothelial cells lining
bone marrow sinuses. MCP1-producing cells in the bone
marrow expressed TLRs and, upon isolation and in vitro culture,
could differentiate into osteoblasts, indicating that these cellsincluded mesenchymal stem cells (MSCs). Targeted deletion of
MCP1 in MSCs resulted in decreased monocyte emigration
from the bone marrow upon LPS stimulation and also resulted
in increased susceptibility to infection with the intracellular
bacterial pathogen L. monocytogenes. Our findings suggest
that MSCs and their progeny, including CXC chemokine ligand
(CXCL)12-abundant reticular (CAR) cells, sense circulating
microbial molecules and, by expressing MCP1, calibrate the
circulating frequency of monocytes in the bloodstream.
RESULTS
Systemic TLR Ligands Induce Monocytosis
To determine whether circulating microbial molecules influence
circulating monocyte levels, we administered highly purified
LPS to mice and measured the frequency of circulating Ly6Chi
monocytes (Figure 1A). LPS administration induced a marked,
TLR4-dependent increase in monocyte frequency between 3
and 6 hr after inoculation (Figure 1B). Stimulation of TLR2,
TLR5, or TLR9 also increased circulating monocyte frequencies
that depended on the expression of the corresponding TLR (Fig-
ure S1 available online). In contrast to monocytes, neutrophil
frequencies continued to increase with increasing doses of
LPS (data not shown). Although low dose LPS markedly
increased circulating monocyte frequencies, this effect was
lost when the dosage of LPS was increased to 2 mg (Figure 1C).Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc. 591
Figure 2. LPS-Induced Emigration Is CCR2,
MCP1, and MyD88 Dependent but TNF and
Type I Interferon Independent
(A and B) WT, Ccl2/, Ccr2/, Tnf/Ifnar1/,
andMyd88/Ifnar1/mice were inoculated with
20 ng LPS. Blood monocyte frequencies were
determined at indicated time points. Data are
represented as mean ± SEM.
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LPS induce sequestration of myeloid cells in different vascular
beds (Andonegui et al., 2003; Andonegui et al., 2009), potentially
obscuring increased emigration of monocytes from the bone
marrow. Alternatively, it is possible that higher levels of circu-
lating LPS promote retention of monocytes in the bone marrow.
Titration of LPS doses and determination of monocyte frequen-
cies at different times after LPS inoculation indicated that higher
LPS doses principally result in retention of monocytes in the
bone marrow with a minor contribution of monocyte sequestra-
tion in the lungs (Figure S2). Administration of low dose LPS
decreased the frequency of inflammatory monocytes in the
bone marrow (Figure 1D), suggesting that increased frequencies
of circulating inflammatory monocytes do not result solely from
demargination of cells from the vascular endothelium or from
a splenic reservoir (Swirski et al., 2009).
The increase in circulating inflammatory monocytes was
dependent on CCR2 and partially dependent on MCP1 (Fig-
ure 2A). Previous studies have demonstrated that MCP1 and
MCP3 both contribute to CCR2-mediated monocyte emigration
from the bone marrow (Jia et al., 2008; Tsou et al., 2007).
Although MCP1 expression can be induced by TLR stimulation
(Tsuboi et al., 2002), inflammatory cytokines such as tumor
necrosis factor (TNF) and type I interferons induce and amplify
MCP1 expression during infection (Jia et al., 2009). Low-dose
LPS, however, induced MyD88-dependent monocyte emigra-
tion from the bone marrow that is independent of TNF and
type I interferon expression (Figure 2B).
CCR2+ Monocytes Traffic to Vascular Sinuses
after TLR Stimulation
Given that the localization of monocytes in the bone marrow has
not been defined, we used a CCR2 reporter mouse strain to
visualize CCR2+ inflammatory monocytes (which represents
the Ly6Chi population), on the basis of the green fluorescent
protein (GFP) expression (Hohl et al., 2009). At the baseline,
CCR2+monocytes werewidely and evenly dispersed throughout
the bonemarrow of themouse femur, generally not directly asso-
ciated with vascular endothelial (VE)-cadherin positive endothe-
lial cells and only rarely within the lumen of blood vessels or
marrow sinuses (Figure 3A). Administration of LPS to mice,
however, changed the localization of CCR2+ monocytes within
2 hr, triggering associationwith VE-cadherin-positive cells at first592 Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc.and leading to increased numbers of
CCR2+ monocytes in the lumen of blood
vessels (Figure 3A). To determine
whether CCR2 signaling is required for
this trafficking, we crossed the CCR2
reporter to the Ccr2/ background and
investigated the response to LPS administration in the bone
marrow (Figure 3B). Trafficking of CCR2+ monocytes into the
circulation depended on CCR2 signaling, and CCR2-deficient
monocytes did not enter the lumen of blood vessels after LPS
administration (Figures 3C and 3D).
Monocyte Emigration Requires MCP1 Production
by Nonhematopoietic Cells
To begin to determine the cellular source of MCP1 that drives the
repositioning of CCR2+monocytes in the bonemarrow after LPS
administration, we generated chimeric mice in which bone
marrow from CCR2 reporter mice was transferred into either
wild-type C57BL/6 recipient mice or mice with a deletion of the
Ccl2 gene, which encodesMCP1 (Gu et al., 1998). LPS treatment
of the bone marrow chimeric mice revealed that MCP1 produc-
tion by host-derived, nonhematopoietic cells drove emigration of
CCR2+ monocytes from the bone marrow and that monocytes
were retained in the bone marrow of MCP1-deficient recipient
mice (Figure 3E). MCP1 deficiency in recipient mice resulted in
diminished frequencies of circulating inflammatory monocytes
(Figure 3F) and diminished association of CCR2+ monocytes
with bonemarrow endothelial cells after LPS administration (Fig-
ure 3G). These results indicate that radiation-insensitive and
presumably nonhematopoietic cells produce MCP1 in response
to LPS administration and thus induce monocyte emigration
from the bone marrow into the circulation.
TLR Stimulation Induces MCP1 production in Proximity
to Vascular Sinuses
Many cell populations, including macrophages, fibroblasts,
endothelial cells, vascular smooth muscle cells, and renal
tubular epithelial cells, are capable of producing MCP1 upon
stimulation with microbial molecules or inflammatory cytokines
(Gu et al., 1998; Ping et al., 1996; Poon et al., 1996; Tsuboi
et al., 2002). We hypothesized that nonhematopoietic cells in
the bonemarrow respond to LPS administration and orchestrate
monocyte emigration by producing MCP1. Because tissue
staining with existing MCP1-specific antibodies was ineffective,
we generated a transgenic reporter mouse strain in which
MCP1 was expressed with a linked GFP that is proteolytically
cleaved to mark MCP1-producing cells. Transgenic mice were
normal in appearance and the transgene, when expressed on
the Ccl2/ background, corrected MCP1 deficiency (Figures
Figure 3. Monocyte Emigration Is CCR2 Dependent and Is Mediated by MCP1 Produced by Nonhematopoietic Cells
(A and B) Fixed-frozen bonemarrow sections from naive and LPS-treated (2 ng/mouse) CCR2 reporter mice (A) and CCR2 reporter-Ccr2/mice (B) were stained
with goat anti-mouse VE-cadherin and counterstained with Hoechst (63X).
(C and D) Quantification of exiting monocyte percentage from CCR2 reporter (C) and CCR2 reporter-Ccr2/ (D) mice after LPS treatment. Exiting monocyte
percentages were calculated by dividing the total number of total GFP+ cells by the number of GFP+ cells within one cell distance of VE-cadherin+ endothelium.
(E) Ccr2.GFP/WT and Ccr2.GFP/ Ccl2/ bone marrow chimeric mice were treated with 2 ng/mouse LPS for 4 hr. Fixed-frozen femurs were stained with
anti-VE-cadherin.
(F) Circulating monocyte frequencies in blood were determined in bone marrow chimeric mice.
(G) The percentage of monocytes associated with VE-cadherin expessing endothelials, defined as exiting monocytes, in bone marrow was calculated. Data are
representative of three independent experiments. Error bars indicate SEM. Scale bars represent 90 mm.
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reporter (M1R) mice became fluorescent upon stimulation with
LPS (Figure S3D) and the fluorescence intensity of bone
marrow-derived macrophages stimulated with a range of LPS
concentrations correlated with the amount of secreted MCP1
(Figure S3E). Because MCP1 production by nonhematopoietic
cells drives monocyte emigration from the bone marrow (Figures3E and 3G), we generated bone marrow chimeric mice in which
M1R mice were the recipients of bone marrow from normal
C57BL/6 mice. We administered LPS to these mice and, 4 hr
later, obtainedmuscle, brain, liver and bone for histological anal-
yses. While we were unable to detect GFP expression in muscle,
brain and liver, we detected marked fluorescence in the bone
marrow (Figure 4A). Much, but not all, GFP expression wasImmunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc. 593
Figure 4. MCP1-Producing Cells in Bone Marrow Colocalize with Vascular Sinuses
(A) WT/M1R bone marrow chimeric mice were inoculated with 20 ng LPS and 4 hr later, muscle, brain, liver, and bone marrow were isolated, fixed, and frozen
and stained for CD31 expression and examined by confocal microscopy for GFP expression. Scale bars represent 90 mm.
(B) Fixed-frozen bone marrow samples at the indicated time points after 20 ng LPS inoculation were stained for CD31 expression and examined by confocal
microscopy. Scale bars represent 47 mm. Data are representative of at least three independent experiments.
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associated with blood vessels in the bone marrow, but not other
tested tissues, might be a source of MCP1 after LPS administra-
tion. Kinetic analysis demonstrated GFP expression in bone
marrow as early as 2 hr and increasing at 4 hr after LPS admin-
istration (Figure 4B).
Bone Marrow Mesenchymal Stem Cells Respond
to TLR Ligands by Producing MCP1
To determine which cell population expresses MCP1 in the bone
marrow after LPS administration, we stained bone marrow
sections for CD31, a marker for endothelial cells. Figure 5A
demonstrates that GFP expression occurred in both CD31+ and
CD31 cells, but that GFP-expressing, CD31 cells were tightly
apposed to endothelial cells. Flow cytometric characterization
of GFP-expressing cells obtained from collagenase-dissociated
bonemarrowdemonstrated that nearly 90%ofMCP1-producing
cells were CD31 negative and VE-cadherin-negative (Figure 5B).
Recent studies have suggested that MSCs might be posi-
tioned adjacent to venous sinuses in the bone marrow and could
give rise to a wide range of cell populations, including osteo-
blasts, adipocytes, chondrocytes, and fibroblasts (Crisan et al.,
2008; Me´ndez-Ferrer et al., 2010; Sacchetti et al., 2007). MSCs
also produce immunomodulatory cytokines but are not known594 Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc.to contribute to antimicrobial defense or to monocyte trafficking
within the bone marrow (BM). CXCL12-abundant reticular (CAR)
cells have been shown to regulate the localization of hematopoi-
etic stem and B lymphoid progenitor cells in the bone marrow
(Sugiyama et al., 2006) and also have progenitor activity, giving
rise to multiple mesenchymal cell types (Omatsu et al., 2010).
To determine whether CD31GFP+ cells contained mesen-
chymal progenitor activity, we sorted CD45GFP+ and
CD45GFP cells from the BM of M1R mice 4 hr after LPS
administration. All the fibroblastic colony-forming units (CFU-F)
and clonogenic capacity of the BM under these culture condi-
tions resided in the CD45–GFP+ fraction (Figure 5C) and was
restricted to the CD31– subset (data not shown). Plating of
CD45–GFP– cells at equal or higher density did not generate
CFU-F. CFU-F derived from CD45–GFP+ cells could produce
osteoblasts after culture and differentiation for 3 weeks (Fig-
ure 5D). Compared to the CD45GFP population, CD45–GFP+
cells were also enriched in the expression platelet-derived
growth factor (PDGF) receptor b and endoglin, two markers of
bone marrow MSCs (Figure 5E). In addition, the expression of
TLR-2, -3, -4, -8, and -9 was higher in CD45GFP+ than in
CD45GFP cells (Figure 5E and Figure S4). BecauseMCP1-ex-
pressing cells after LPS administration did not express CD45,
Ter119 (a lineage marker for erythroid cells), Sca1 (stem cell
Figure 5. Marrow Endothelial Cells and Tightly Associated MSCs Produce MCP1 and Promote Monocyte Emigration
(A) M1R mice were inoculated with 20 ng LPS and 4 hr later bone marrow was sectioned and stained. GFP+ MCP1-producing cells after LPS stimulation overlap
(upper) or are tightly associated (lower) with CD31+ endothelial cells. Scale bars represent 12 mm.
(B) Bone marrow from stimulated mice was harvested and dissociated, and CD45GFP+ cells (left panel) were stained for expression of CD31 and VE-cadherin
(right panel).
(C) CD45GFP+ and CD45GFP cells were flow cytometrically sorted from M1R mice after LPS inoculation and cultured for CFU-F.
(D) CD45GFP+ cells were further differentiated in vitro to osteoblasts.
(E) Pdgfrb, Eng, and Tlr4 expression in sorted cells were measured by Q-PCR.
(F) Expression of GFP and PDGFR-b by a CD45Ter119CD31Sca1 population in the bone marrow.
(G) CD45Ter119GFP+ cells and CD45Ter119 CD31+Sca1+ endothelial cells were sorted and CXCL12 mRNA expression was quantified by Q-PCR.
(H) CD45CD31GFP+ and CD45CD31+GFP+ cells were sorted and MCP1mRNA expression was quantified by Q-PCR. Data are represented as mean ± SEM.
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could also be classified as CAR cells. Indeed, MCP1-expressing
cells also expressed high amounts of CXCL12 (Figure 5G). These
results suggest that BMperivascularMSCs and/or CAR cells can
detect circulating TLR ligands and produceMCP1, thus directing
monocyte emigration from the bone marrow into the blood-
stream. Although some endothelial cells express MCP1 in
response to LPS administration, the majority of cells expressing
MCP1were VE-cadherin and CD31 negative. To further measure
MCP1 production by bone marrow endothelial cells and MSCs,
we sorted these two populations and determined MCP1 mRNA
amounts. Figure 5H demonstrates that MCP1 expression was
induced in both populations after LPS stimulation and that
MSCs expressed slightly higher MCP1 mRNA amounts than
endothelial cells on a per cell basis.To determine whether bone marrow MSCs and their progeny
induce monocyte emigration by secreting MCP1 in response to
LPS stimulation, we used a genetic approach to conditionally
delete the Ccl2 gene from MSCs. Recent studies have demon-
strated that bone marrow MSCs express Nestin and that the
mesenchymal activity and clonogenicity of CD45 cells reside
within the Nestin+ population (Me´ndez-Ferrer et al., 2010). We
generated a conditional Ccl2-targeted mouse strain by inserting
loxP sites that flank exons 2 and 3 of the Ccl2 gene and also
tagged MCP1 with the HA epitope and a linked but cleaved
red fluorescent protein (RFP) gene to act as a reporter (Fig-
ure S5A). Conditional deletion ofCcl2 in MSCs and their progeny
was accomplished by crossing Ccl2-RFPflox/flox mice with mice
expressing Cre recombinase under the control of Nes promoter.
Of note, MCP1-expressing cells were found to express higherImmunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc. 595
Figure 6. MCP1 Produced by Nestin-Expressing MSCs Is Required for Optimal Monocyte Emigration after LPS Stimulation
Ccl2-RFPflox/flox, Ccl2-RFPflox/flox expressing Nes-Cre or Tek-Cre, and Ccl2/ mice were inoculated with LPS. Four hours after stimulation, (A) bone marrow
was sectioned and stained. Scale bars represent 40 mm. As shown in (B), blood was obtained analyzed by flow cytometry for determining CD11b+Ly6Chi
monocyte frequencies in the circulation. The emigration kinetics of CD11b+Ly6Chi monocytes and CD11b+Ly6G+ neutrophils are shown in (C) and (D). Error bars
indicate SEM.
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Histological analyses of bone marrow sections after LPS admin-
istration revealed that MCP1 expression, as visualized by RFP
induction, was markedly diminished in Nes-Cre expressing
mice (Figure 6A and Figure S5C). Expression of MCP1 tran-
scripts in bone marrow endothelial cells of LPS-treated mice
was unaffected by Nes-Cre expression in Ccl2-RFPflox/flox mice
(Figure S5D). In contrast, in Tek-Cre-expressing mice, in which
theCcl2 genewould be deleted in endothelial and hematopoietic
cells, MCP1 expression was only modestly diminished (Fig-
ure 6A, right panel, and Figure S5C). The percentage of circu-
lating Ly6Chi monocytes was significantly decreased after LPS
stimulation in Nes-Cre.Ccl2-RFPflox/flox mice (Figures 6B and
6C), suggesting that MCP1 production by Nestin-expressing
cells drives monocyte emigration from the bone marrow. In
contrast, circulating Ly6G+ neutrophils were not affected (Fig-
ure 6D). The lack of MCP1 in endothelial cells, as determined
in Tek-Cre.Ccl2-RFPflox/flox mice, significantly decreased mono-
cyte emigration, although to a lesser extent (Figure 6B). LPS-
induced monocyte emigration from the bone marrow was not596 Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc.affected in Ccl2-RFPflox/flox expressing Lyz2-Cre or Alb-Cre,
which removes MCP1 from myeloid lineage and hepatocytes,
respectively (Figure S6). These findings suggest that MSCs
and CAR cells function as the predominant sensors of circulating
LPS amounts and, by producing MCP1 in the bone marrow,
determine the frequency of circulating inflammatory monocytes.
Infection with Listeria monocytogenes Induces MCP1
Expression by Bone Marrow Mesenchymal Stem Cells
Previous studies have demonstrated that infection with
L. monocytogenes, an intracellular bacterial pathogen, induces
CCR2-dependent emigration of monocytes from the bone
marrow (Serbina and Pamer, 2006). To determine whether non-
hematopoietic cells produce MCP1 and promote monocyte
trafficking during bacterial infection, we used wild-type and
Ccl2/ mice to generate bone marrow chimeric mice. After
L. monocytogenes infection, the majority of MCP1 was pro-
duced by nonhematopoietic cells and MCP1 production by non-
hematopoietic cells was required for monocyte emigration from
bone marrow (Figure 7A). We infected CCR2 reporter mice with
Figure 7. MCP1 Production by Bone Marrow MSCs Enhances Resistance to Listeria monocytogenes Infection
(A) Bone marrow chimeric mice were infected with 3000 L. monocytogenes. Twenty-four hours after infection, serum was harvested for MCP1 ELISA (upper
panel) and bone marrow cells were harvested for Ly6Chi monocyte quantification (lower panel).
(B) CCR2 reporter (upper panel) and CCR2 reporter-Ccr2/ mice (lower panel) were infected with L. monocytogenes. The percentages of exiting monocytes
were quantified at different time points after infection.
(C) WT-M1R bone marrow chimeric mice were infected with L. monocytogenes. Fixed-frozen sections were prepared at different time points and stained for
CD31 expression and examined by confocal microscopy. Data are representative of at least three independent experiments.
(D–I) Ccl2-RFPflox/flox, Ccl2-RFPflox/flox expressing Nes-Cre or Tek-Cre, and Ccl2/ mice were infected with L. monocytogenes. CD11b+Ly6Chi monocyte
frequencies in the circulation (D and G) and the bone marrow (E and H) were determined by flow cytometry at day 1 after infection and the number of viable
L. monocytogenes from spleens was quantified at day 3 after infection (F and I). Data are represented as mean ± SEM.
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the bone marrow. Within 4 hr of infection, we detected mobiliza-
tion of monocytes and by 12 hr, most CCR2+ monocytes were
associated with cells lining bone marrow venous sinuses (Fig-
ure 7B and Figure S7). Along similar lines, MCP1-GFP expres-
sion in bone marrow was detected 12 hr and 24 hr after infection(Figure 7C) and, as after LPS administration, was tightly associ-
ated with CD31+ endothelial cells. The delay relative to LPS
administration probably reflected the requirement for threshold
levels of microbial molecules to be introduced into the circulation
by expanding bacterial populations. Infection of Nes-Cre.Ccl2-
RFPflox/flox mice with L. monocytogenes resulted in diminishedImmunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc. 597
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MSCs Induce Monocyte Emigrationemigration of Ly6Chi monocytes from the bone marrow into the
bloodstream (Figures 7D and 7E). Impaired monocyte recruit-
ment resulted in diminished clearance of bacteria from the
spleen (Figure 7F). Deletion of MCP1 from endothelial cells and
hematopoietic cells by Tek-Cre also diminished the emigration
of Ly6Chi monocytes, albeit to a lesser extent (Figures 7G and
7H). Infected Tek-Cre.Ccl2-RFPflox/flox mice had higher bacterial
counts in the spleen, although the difference did not reach
a statistically significant level (Figure 7I). These findings indicate
MSCs and CAR cells, and to a lesser extent endothelial cells, are
functionally relevant sources of MCP1 during bacterial infection.
DISCUSSION
Inflammatory monocytes have been implicated in defense
against viral, bacterial, fungal, and protozoal infections (Serbina
et al., 2008). Most of these infections do not directly involve the
bone marrow, raising the question of how monocytes are in-
structed to emigrate from the bone marrow into the circulation.
Our studies demonstrated that very low levels of circulating
TLR ligands promote the release of bone marrow monocytes
into the bloodstream, thus providing these pluripotent cells
with an opportunity to circulate to sites of infection or inflamma-
tion. Ideally, inflammatory monocytes should reach their target
early during infection, so they can optimize pathogen clearance
by differentiating into microbicidal cells and marshaling addi-
tional inflammatory cell populations. Although inflammatory
monocytes generally enhance defense against infection, in
some circumstances, such as during infection by highly virulent
strains of influenza virus, robust recruitment of inflammatory
monocytes is associated with increased mortality (Aldridge
et al., 2009).
Inflammatory monocytes have also been implicated in the
pathogenesis of autoimmunity (Huang et al., 2001), atheroscle-
rosis (Boring et al., 1998; Gu et al., 1998) and other clinical condi-
tions (Swirski et al., 2009). In these circumstances, the density of
circulating inflammatory monocytes may contribute to the initia-
tion and/or progression of pathology. Given our finding that low
doses of intravenously administered TLR ligands markedly
increased circulating numbers of inflammatory monocytes, it is
possible that fluctuations in the amounts of microbial molecules
absorbed from mucosal surfaces contribute to the progression
of inflammatory diseases. In this scenario, increases in epithelial
permeability to microbial molecules could result in increased
expression of MCP1 by bone marrow MSCs and CAR cells
and the release of monocytes into the circulation. The intestinal
microbial flora introduces peptidoglycan-derived molecules
into the circulation and stimulates NOD1 receptors in bone
marrow neutrophils, demonstrating the plausibility of a model
of innate immune activation by intestinally absorbed microbial
molecules (Clarke et al., 2010). In other studies, marked variation
in the amount of circulating LPS in humans has been associated
with the lipid composition of the diet (Erridge et al., 2007; Gho-
shal et al., 2009). Circulating LPS has also been implicated in
the progression of HIV infection (Brenchley et al., 2006).
We found that in vivo MCP1 expression under baseline condi-
tions (i.e., in the absence of LPS administration and in uninfected
mice) was very low in the blood and in the bone marrow, as
determined by MCP1 ELISA or by fluorescence microscopy of598 Immunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc.theM1Rmouse strain and that LPS administration or L. monocy-
togenes infection induced de novo production of MCP1. This
result contrasted with a recent study that uses transgenic mice
to report MCP1 expression in the bone marrow before and after
LPS administration (Jung et al., 2009). One important difference
between our studies is the dosage of LPS. Whereas Jung et al.
administered 200 mg of LPS, we found that monocyte emigra-
tion from the bone marrow was induced by much lower doses of
LPS and, surprisingly, not induced by LPS doses exceeding
2 mg. Thus, we believe that our experiments are characterizing
vastly different events, with Jung et al.’s system approximating
the pathophysiology of septic shock, whereas our system
more closely resembled early stage and far less severe infec-
tions. Furthermore, monocyte responses to very low amounts
of circulating LPS may model events that occur during low-level
fluctuations in circulating microbial molecules after their absorp-
tion from the gut. A second difference between our studies is the
disparity in baseline expression of MCP1 inmice. Here, we spec-
ulate that colonization of mice with different flora, and perhaps
the presence or absence of intestinal microbes such as Helico-
bacter hepaticus or segmented filamentous bacterium, may
have enhanced MCP1 expression in the bone marrow. Deter-
mining whether the composition of the intestinal microbial flora
influences MCP1 expression and monocyte trafficking from the
bonemarrow into the blood stream requires further investigation.
Recruitment of monocytes from the bone marrow during
systemic infection with complex organisms such as Listeria
monocytogenes or Toxoplasma gondii is probably mediated by
multiple redundant pathways that include TLR signaling but
also TLR-independent induction of inflammatory cytokines and
chemokines. Thus, although we demonstrated that TLR stimula-
tion by LPS can induceMCP1 production by bonemarrowMSCs
and CAR cells, leading to the emigration of Ly6Chigh monocytes
into the bloodstream, previous studies from our laboratory have
also demonstrated that in the setting of L. monocytogenes infec-
tion, monocyte emigration from the bone during early time points
after bacterial inoculation is MyD88 independent (Serbina et al.,
2009; Serbina et al., 2003). Monocyte emigration from the bone
marrow is markedly diminished, however, in the combined
absence of both MyD88 and the type I interferon receptor (Jia
et al., 2009), suggesting that, in the setting of bacterial infection,
bone marrow MSCs can express MCP1 in response to inflam-
matory cytokines, such as type I interferon, in the absence of
TLR-mediated signals.
Our studies demonstrated mesenchymal stem cells and
CAR cells in the bone marrow sense circulating TLR ligands
and, by producing MCP1, modulate the frequency of blood-
stream Ly6Chi CCR2+ monocytes. This mechanism calibrates
the host’s innate immune tone, on one hand enhancing antimi-
crobial defenses, while, on the other hand, potentially exacer-
bating noninfectious inflammatory diseases. How reticular cells
in bone marrow orchestrate monocyte emigration from the
bone marrow, beyond producing MCP1, remains unclear. It is
possible, given that the endothelium of the bone marrow is
fenestrated (Tavassoli and Shaklai, 1979), that MSCs or CAR
cells directly abut the vascular compartment and thus guide
monocytes into the bloodstream. Alternatively, bone marrow
reticular cells may express MCP1 on the abluminal side of endo-
thelial cells, thus guiding monocytes to vascular sites at which
Immunity
MSCs Induce Monocyte Emigrationpoint other trafficking mechanisms may be activated to enable
entry into the bloodstream. Additional studies will be required
to distinguish between these possibilities. Deeper understanding
of these processes may lead to novel therapeutic approaches to
control monocyte emigration from bone marrow and monocyte
frequencies in the circulation.
EXPERIMENTAL PROCEDURES
Mice
All mice used in this study were bred at Memorial Sloan-Kettering Research
Animal Resources Center. Ccl2/, Ccr2/, and CCR2 reporter mice were
previously described (Hohl et al., 2009; Jia et al., 2008). Ifnar1/ mice were
purchased from B&K Universal. Myd88/ mice were obtained from S. Akira
(University of Osaka, Osaka, Japan). We crossed Ifnar1/ and Myd88/
mice strains to obtain Myd88/Ifnar1/ mice. We crossed M1R mice with
Ccl2/ mice to obtain the M1R-Ccl2/ strain and crossed CCR2 reporter
mice with Ccr2/ mice to obtain the CCR2 reporter-Ccr2/ strain. All mice
were either generated on the C57BL/6 background or backcrossed at least
ten generations onto the C57BL/6 background. Mice were housed in a specific
pathogen-free facility and all animal studies were conducted in compliance
with protocols approved by the animal care committee at Memorial Sloan-Ket-
tering Cancer Center.
Generation of MCP1 Reporter
MCP1 reporter (M1R) mice were generated by bacterial artificial chromosome
(BAC)-mediated transgenesis with the recombineering strategy described
by Heintz and colleagues (Gong et al., 2002). In brief, the endogenous Ccl2
locus was identified on BAC clone RP23-328G11 (220 kb in size; obtained
from CHORI) derived from chromosome 11 by polymerase chain reaction
(PCR) screening of candidate BACs mapped to this region. A 2.5 kb fragment
that contained 500 bp upstream and 2.0 kb downstream of the Ccl2 gene
start codon was amplified and modified immediately upstream of the stop
codon in exon 3 of the Ccl2 gene by insertion of nucleotides encoding the
HA peptide (-YPYDVPDYA-), followed by a 19 residue aphthovirus 2A
cleavage site (-APVKQTLNFDLLKLAGDVESNPGP-) (Donnelly et al., 2001),
a furin cleavage site (-RAKR-) (Thomas, 2002), and aa 2–239 of enhanced
GFP (Tsien, 1998). The GFP coding sequence was followed by a stop codon.
The resulting 3.3 Kb fragment was cloned into AscI and NotI sites in the shuttle
vector pLD53SC.AB, obtained from D.R. Littman (New York University,
New York, NY).
To modify the BAC clone RP23-328G11 for transgenesis, we integrated the
shuttle vector containing the 3.3 kb Ccl2.GFP insert into the BAC by homolo-
gous recombination and selected cointegrates by chloramphenicol and
ampicillin treatment. Resolution of cointegrates through a second homologous
recombination event was achieved by negative selection on sucrose, resulting
in the complete excision of the shuttle vector backbone that includes the SacB
gene (for details, see Gong et al., 2002). The resulting modified BAC encoding
GFP under control of the endogenous Ccl2 promoter and regulatory elements
was analyzed by Southern blotting for verification of GFP integration at the
expected site, the Ccl2 gene was sequenced, purified by centrifugation
through a cesium chloride gradient, and injected into fertilized C57BL/6
oocytes. Two potential founder animals were identified among 41 offspring
screened by PCR.
Generation of Ccl2-Targeted Mice
The floxed Ccl2 mouse strain was generated with standard gene targeting
protocol using Cre-lox and Flp-Frt recombination systems. In brief, mouse
genomic sequences of the Ccl2 gene were isolated from BAC clone RP23-
328G11 (obtained from CHORI) and modified by tagging the 30 end with
a cleavable RFP (mcherry) as described in the methods of generating M1R.
The targeting vector was constructed by cloning the modified sequences
together with 3 kb and 5 kb homologous regions flanking the Ccl2 locus into
plasmid pEZ-Frt-lox. Two LoxP sites were introduced and flank the second
and third exons, which encode the functional domain of MCP1. The linearized
targeting vector was transfected into embryonic stem cells derived from the
C57BL/6 strain. Homologous recombinants were drug selected with G418and ganciclovir and further identified by Southern blot analysis. Clones
carrying the mutated allele of the Ccl2 gene were injected into blastocysts
and implanted into pseudopregnant foster mice. Chimeric progeny were
bred to C57BL/6mice, and the F1 generation was screened for germline trans-
mission of the mutated allele. The neomycin resistance gene carried on the
mutate allele and flanked with Frt sites was removed by breeding to transgenic
mice carrying the gene encoding flippase. The resultant floxed MCP1 RFP
mice were maintained and named Ccl2-RFPflox/flox. We generated mice with
tissue specific, conditional deletion of Ccl2 by breeding Ccl2-RFPflox/flox to
transgenic strains carrying Nes-Cre, Tek-Cre, Lyz2-Cre, Alb-Cre, respectively
(all purchased from Jackson Laboratories).
TLR Stimulation and L. monocytogenes Infection
LPS (tlrl-pelps), Pam3Cys (tlrl-pms), Flagellin (tlrl-pstfla), and CpG (tlrl-modna)
were purchased from InvivoGen (San Diego, CA). Mice were injected intraper-
itoneally (i.p.) with 20 pg–2 ug LPS, 200 ng Pam3Cys, 200 ng Flagellin, and
20 mg CpG. Bacteria were grown to log phase (A600 of 0.1), and mice were in-
fected intravenously (i.v.) with 3000 L. monocytogenes strain 10403S as
described previously (Jia et al., 2008).
Bone Marrow Immunofluorescence
Mice were euthanized and perfused with 4% paraformaldehyde. Femurs
were postfixed, cryoprotected, and snap frozen in OCT compound. Sections
(12 mm) were blocked (5% donkey serum) and incubated at 2 mg/ml in primary
rat anti-CD31 (MEC-13.3, BD 550274), goat anti-VE-cadherin (R&D BAF1002),
and rabbit anti-RFP-biotin (Abcam ab34771). After incubation in fluorophore-
conjugated secondary antibodies at 1 mg/ml, donkey anti-rat IgG Alexa 594
(A21209, Invitrogen), donkey anti-goat Cy3 (705-165-147, Jackson IR), and
streptavidin-Texas Red (200-072-211, Jackson IR), sections were counter-
stained with Hoechst 33342 (H3570, Invitrogen). Images were acquired with
Leica TCS SP2 AOBS laser scanning confocal microscope with 203 and
633 objective lens.
Flow Cytometry
Single-cell blood, bone marrow, and spleen samples were prepared as
described before (Jia et al., 2008). In brief, blood samples were harvested
from mouse-tail and resuspended in heparin. Bone marrow cells were
collected by flushingmouse femurs with ice-cold PBS. To obtain bonemarrow
endothelial cells andMSCs, we further digested bonemarrow cells in 10mg/ml
collagenase type IV (Worthington) and 20 U/ml DNase (Roche) at 37C for
40 min. Spleens were harvested, minced in PBS, 5% FCS, 3 mg/ml collage-
nase type IV (Worthington), and 20 U / ml DNase (Roche) and were incubated
at 37C for 60 min. Lysis of red blood cells was performed and samples were
resuspended in ice-cold PBS with 1% BSA. Cell suspensions were enumer-
ated with a Z2 Coulter counter (Beckman Instruments) with a 6–15 mmwindow
and analyzed on a BD LSR II cytometer. All antibodies were purchased from
BD Biosciences unless otherwise stated. The staining protocols included
combinations of the following antibodies: anti-Ly6C (clone AL-21, FITC),
anti-Ly6G (1A8, PE), anti-CD11b (M1/70, PerCP-Cy5.5), anti-CD45 (30F-11;
APC), anti-CD31 (MEC-13.3, PE), and anti-VE-cadherin (BAF1002, R&D).
CFU-F Assay from Sorted Cells
CD45 GFP+ and CD45 GFP cells were flow cytometrically sorted from the
BM of M1R transgenic mice 4 hr after LPS administration and cultured with
red-phenol-free a-MEM medium supplemented with 15% FBS and 1% peni-
cillin-streptomycin (Invitrogen) at 37C under 5% CO2 in a water-jacketed
incubator. Half-medium changes were performed every 3–4 days. Fibroblastic
colonies were counted after 10 days in culture. Osteoblastic differentiation
was induced by culturing cells for 3 weeks with 50 mg/ml L-ascorbic acid
2-phosphate, 10 mM glycerophosphate (Sigma), and 15% FBS in a-MEM
with 1% penicillin-streptomycin (Invitrogen).
RNA Isolation and Quantitative Real-Time RT-PCR
Sorted cells were collected in lysis buffer and RNA isolation was performed
with the Dynabeads mRNA DIRECT Micro Kit (Invitrogen). Conventional
reverse transcription, with the Sprint PowerScript reverse transcriptase (Clon-
tech), was performed in accordance with the manufacturers’ instructions.
Quantitative real-time RT-PCR (Q-PCR) was performed with SYBR GREENImmunity 34, 590–601, April 22, 2011 ª2011 Elsevier Inc. 599
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MSCs Induce Monocyte Emigrationon an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems).
Primers were designed with the Primer Express software (Applied Biosystems)
and when possible were selected to span introns for preventing the amplifica-
tion of contaminating genomic DNA. A primer concentration of 300 nM was
found to be optimal in all cases. The sequences of the oligonucleotides used
are available upon request. The PCR protocol consisted of one cycle at
95C (10 min) followed by 40 cycles of 95C (15 s) and 60C (1 min). A disso-
ciation curve analysis was included after each experiment so that the presence
of a single product and the absence of primer dimmers could be confirmed.
Expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
generally used as a standard. The average threshold cycle number (Ct) for
each tested mRNA was used for quanitifying the relative expression of each
gene: 2^[-Ct(gene)-Ct(GAPDH)].
ELISA
Murine MCP1 was quantified with an ELISA kit from BD Biosciences. Blood
was harvested and clotted to obtain serum for ELISA. For obtaining organ
lysates for chemokine assays, organs were harvested at the indicated times
after infection, macerated in ice-cold PBS containing 0.01% Triton X-100,
and centrifuged at 10,000 3 g.
Statistical Analyses
The unpaired Student’s t test was used for statistical analyses with GraphPad
Prism 5.0 software. p values were calculated by t test; *p < 0.05, **p < 0.01,
***p < 0.001. p < 0.05 was considered statistically significant. Error bars
indicate SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.immuni.2011.02.016.
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